Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ERTglobal
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ERTglobal
-
Patient micropayments don’t need to be cost prohibitive for sponsors. Learn about the benefits of small patient payments on retention and compliance. https://ert.co/35izN5G pic.twitter.com/OvIUAqMR8D
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn when to assess suicidal ideation and behavior (SIB) during clinical trials and why enabling patients to self-report produces more candid, honest responses. https://ert.co/2to9EVS pic.twitter.com/v8MOeSqfvy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ERT proslijedio/la je Tweet
Technology company
@ERTglobal plays a role in supporting decentralized#clinicaltrials, improving access for patients.https://twitter.com/ERTglobal/status/1204745926532849665 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Understand the factors that impact the success of ABPM during clinical trials and how to ensure valid and useful data is collection for regulatory submissions. https://ert.co/2LIq9nb pic.twitter.com/2Cl4Zxd7zH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Look past wearables and get a glimpse into the next step in collecting clinical trial patient data. Learn more about passive health monitoring on Trial Better. https://ert.co/2RiFtcj pic.twitter.com/gOyoKHjGew
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn how AI-based imaging and performance risk/management can speed up
#clinicaltrials & reduce costs…if you start with a modern, scalable data platform. https://ert.co/30VXmyF pic.twitter.com/7HbyOj6rR1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Make go/no go decisions sooner, ensure promising drugs aren’t eliminated and show product value earlier through Phase I QT assessment. https://ert.co/30ErXm3 pic.twitter.com/5fyBgZhaRj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn how new technologies can improve patient satisfaction and keep them better engaged throughout clinical trials. https://ert.co/2qMzTUK pic.twitter.com/EJ5iwGfu8O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For capturing primary endpoints in phase 3 and in many other situations, the use of eCOA is critical to ensuring your
#clinicaltrial’s success.https://ert.co/2kFmFpN pic.twitter.com/qDwvwBkAhj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn how subspecialist readers improve
#clinicaltrial imaging by providing a higher level of disease / organ knowledge and deeper expertise which translates to better interpretations. https://ert.co/2QSlFfn pic.twitter.com/GsvtyF2lmY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How is ERT meeting the complex data needs of clinical trial sponsors? Through a cloud-based, real-time data and analyti platform that ingests all clinical data at scale from any data source. https://ert.co/2ZTtS5K pic.twitter.com/Yym2zIHYwK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn how ERT's innovative Imaging Technology is not only benefitting life on earth, but also advancing space exploration research. https://ert.co/36p0hDQ pic.twitter.com/2iSBvFyXen
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ABPM is the best way to comply with FDA guidelines while keeping patients safe in
#clinicaltrials. Learn more about the latest FDA blood pressure guidance and ABPM.https://ert.co/2FkPZJ7 pic.twitter.com/behP3BE4zB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to work with our customers as they bring new treatments to the patients who need them, quickly. Looking forward to our continued partnerships in the new year!pic.twitter.com/KRlihdtZrm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn how Clinical Trial Consultants - a Swedish CRO - collaborates with ERT to collect important QT data at a very early stage, helping their clients qualify for a TQT waiver and recognize huge cost savings. https://ert.co/2qXo91E pic.twitter.com/MPkSySuA7m
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Coming to Trial Better: our year-end podcast series, featuring quick insights from ERT's clinical research and technology experts. We're launching a new edition every day, starting today. Don't miss it! https://ert.co/2ElD1dx pic.twitter.com/aqEYXWB4EG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meeting regulatory standards is as easy as 1-2-3! Learn the strategies that deliver the highest quality
#clinicaltrial respiratory data. https://ert.co/2RJ2dlQ pic.twitter.com/cMIR04IWdu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bringing digital health technologies to patients’ homes is the next advancement in clinical research. Learn more on Trial Better. https://ert.co/2YgOUdD pic.twitter.com/aczWtKbgii
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We all want to keep patients safe. But, automated ECG machine measurements are not answer. Avoid false negative / positive ECG readings by centralizing cardiac safety assessments in clinical trials. https://ert.co/2E1R9Z3 pic.twitter.com/FR8ZaD1KFa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Optimize imaging processes in oncology clinical trials to demonstrate the cardiac safety of new compounds more efficiently. Learn how! https://ert.co/2CR3COG pic.twitter.com/xqwvjGf5JL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.